Measurement of a progestational and antiandrogenic compound by a competitive protein binding assay.
D000284:Administration, Oral; D000818:Animals; D001667:Binding, Competitive; D002845:Chromatography; D002855:Chromatography, Thin Layer; D003429:Cross Reactions; D004285:Dogs; D004355:Drug Stability; D005069:Evaluation Studies as Topic; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D008524:Medrogestone / Q000008:administration & dosage / Q000097:blood; D008722:Methods; D011245:Pregnadienes / Q000097:blood*; D011247:Pregnancy; D011374:Progesterone; D011372:Progestins / Q000097:blood*; D011485:Protein Binding; D011869:Radioligand Assay; D012822:Silicon Dioxide; D013696:Temperature; D013997:Time Factors; D014316:Tritium
D011245:Pregnadienes; D011372:Progestins; D008524:Medrogestone; D014316:Tritium; D011374:Progesterone; D012822:Silicon Dioxide